0.00-0.70 10 3/uL
-
TCH MAIN
LAB
Basophils (ABS #)
0.04
0.00-0.10 10 3/uL
-
TCH MAIN
LAB
CBC Differential Charge
Option
AUTOMATED DIFF
Component
Value
Ref Range
Flag
Comment
Lab
Hematocrit
31.6
33-43 %
L
Delta: 38.9 on
0750
TCH MAIN
LAB
Component
Value
Ref Range
Flag
Comment
Lab
Color (1)
YELLOW
-
TCH MAIN
LAB
Character (2)
CLEAR
-
TCH MAIN
LAB
Glucose-UA
NEGATIVE
NEGATIVE MG/DL
-
TCH MAIN
-
TCH MAIN
LAB

IP Encounter Report
MRN:
DOB:
Sex: M
Adm:
D/C:
Lab - Results (continued)
URINALYSIS WITH MICROSCOPIC [39128721] (Abnormal) (continued)
Resulted:
0856, Result Status: Final result
Testing Performed By
Lab - Abbreviation
Name
Director
Address
Valid Date Range
7 - TCH MAIN LAB
CHILDREN'S HOSPITAL
COLORADO
LABORATORY
Mark A. Lovell MD,
Medical Director, eff
13123 East 16th Avenue
Aurora CO 80045
1552 - Present
8 - Unknown
TCH RADIOLOGY
Unknown
Unknown
0000 - Present
All Meds and Administrations
(MR #
Printed by
[103311] at 10/11/13 10:09 AM
Page 56
TCH MAIN
LAB
Nitrite-Urine
NEGATIVE
NEGATIVE
-
TCH MAIN
LAB
Leukocytes
NEGATIVE
NEGATIVE
-
TCH MAIN
LAB
WBC, Urine
None Seen
0-5 /hpf
-
TCH MAIN
LAB
RBC-Urine
4-10
0-3 /hpf
H
-
TCH MAIN
LAB
RBC Morphology, UA
CRENATED
NORMAL
-
TCH MAIN
LAB
Mucus
Small
None Seen /lpf
-
TCH MAIN
LAB
Bacteria, Urine
None Seen
None Seen /hpf
-
TCH MAIN
LAB
Comments, Urine Micro
12.0ML
-
TCH MAIN
LAB
LAB
Bilirubin,Urine
NEGATIVE
NEGATIVE
-
TCH MAIN
LAB
Ketones, Urine
NEGATIVE
NEGATIVE mg/dL
-
TCH MAIN
LAB
SP - Urine
1.010
1.003-1.030
-
TCH MAIN
LAB
Chemical Blood-Urine
TRACE-INTACT
NEGATIVE
-
TCH MAIN
LAB
PH-Urine
6.5
5.0-9.0
-
TCH MAIN
LAB
Protein, Urine
NEGATIVE
NEGATIVE MG/DL
-
levofloxacin in D5W (dextrose 5%) (5 mg/mL) 201 mg [39050126]
Status: Completed (Past End Date/Time)
TCH MAIN
LAB
Urobilinogen-UA
0.2
0.2-1.0 E.U./dL
-
Rate/Duration:
- / -
Admin Instructions:
Administer prior to incision.
Comments:
**Please make sure start date and time are correct**
Recommended dose: 10 mg/kg/dose IV (max = 500 mg/dose) x1 dose pre-
op (do NOT re-dose intraoperatively).
Ordering Provider:
Ballard, Michael R.
Administration
Status
Dose
Route
Site
Given By
0804
Canceled
Entry
Intravenous
Casias, Timothy W.
0800
Due
0744
Given
201 mg
Intravenous
Casias, Timothy W.
Ordered On:
0619
Starts/Ends:
0800 -
0744
Dose (Remaining/Total):
10 mg/kg/dose (0/1)
Frequency:
ONCE IN OR
Route:
Intravenous

IP Encounter Report
MRN:
DOB:
Sex: M
Adm:
D/C:
All Meds and Administrations
(continued)
(MR #
Printed by
[103311] at 10/11/13 10:09 AM
Page 57
tranexamic acid 1,250 mg in NS (0.9% sodium chloride) 25 mL [39063758]
Status: Discontinued (Past End Date/Time), Reason: Patient
Discharged
acetaminophen (conc: 160mg/5mL) oral suspension 302 mg [39065668]
Status: Verified (Past End Date/Time)
clindamycin in D5W (dextrose 5%) (conc: 18 mg/mL) 201 mg [39050127]
Status: Completed (Past End Date/Time)
HYDROmorphone (conc: 2mg/mL) injectable 0.1-0.3 mg [39065669]
Status: Verified (Past End Date/Time)
tranexamic acid (conc: 100mg/mL) injection 1,005 mg [39063757]
Status: Dispensed (Past End Date/Time)
Route:
Intravenous
Rate/Duration:
- / -
Admin Instructions:
Infuse over 30 minutes
Comments:
Admin Instructions:
Administer prior to incision. Infuse over 10-60 minutes.
Comments:
**Please make sure start date and time are correct**
Recommended dose: 10 mg/kg/dose IV (max = 900 mg/dose) x1 dose pre-
op (re-dose Q6H intraoperatively).

